ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Merck in Talks to Buy Indian Pharmaceutical Ingredients Maker Micro Labs - Report

Merck & Co. Inc. (MRK) is in talks to acquire Indian active pharmaceutical ingredients maker Micro Labs Ltd., the Financial Express reported Thursday, citing an unidentified person aware of the matter. The newspaper said Bangalore-based Micro Labs is a privately held company, founded and run by the Surana family. Micro Labs aims to achieve sales of about $1 billion by 2015, the report said, citing the company's website. A Merck India spokesperson declined to comment to the newspaper on any possible deal. Newspaper website: http://www.financialexpress.com Write to djn.in@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
08/28/201516:00:00FDA: Some Diabetes Drugs Can Cause Joint Pain
08/20/201508:30:00New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN®...
08/18/201513:17:00Merck Recalls TEMODAR® and Temozolomide Bottles with Cracked...
08/18/201508:00:00FDA Accepts Supplemental Biologics License Application (sBLA...
08/14/201508:00:00Celebrity Chef Leticia Moreinos Schwartz, Merck and the American...
08/13/201508:00:00Merck and MD Anderson Cancer Center Announce Strategic Immuno-Oncology...
08/06/201516:38:34Quarterly Report (10-q)
08/04/201514:43:05Statement of Changes in Beneficial Ownership (4)
08/04/201514:43:05Statement of Changes in Beneficial Ownership (4)
07/31/201519:27:51WHO Says Ebola Vaccine Effective in African Trial -- Update
07/31/201515:16:17WHO Says Ebola Vaccine Effective in African Trial -- Update
07/31/201509:00:04WHO Says Ebola Vaccine Effective in African Trial
07/31/201509:00:03WHO Says Ebola Vaccine Effective in African Trial -- Update
07/31/201508:47:49WHO Says Ebola Vaccine Effective in African Trial
07/31/201508:10:00In Interim Results from Phase 3 Study, Merck’s Investigational E...
07/30/201508:00:00Celebrity Chef Leticia Moreinos Schwartz, Merck and the American...
07/28/201517:00:35Gilead Sales Soar on Hepatitis Drugs
07/28/201516:34:36Current Report Filing (8-k)
07/28/201516:15:00Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board...
07/28/201512:26:16Merck Earnings Hurt by Arthritis Drug Knockoffs

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad